Telefonaktiebolaget Lm Ericsson (Pub) v. Xiaomi Technology & Ors

64182738

Ericsson sued Xiaomi for infringing several patents related to AMR, 3G, and EDGE technology used in mobile devices. The defendants filed an application seeking vacation of a prior interim injunction by alleging concealment of material facts. The court found that Ericsson failed to disclose its agreement with Qualcomm regarding CDMA applications, leading to the vacation of the interim order concerning two specific patents.

Jurisdiction
India
Court
Delhi High Court
Case Number
64182738
Judge(s)
V.Kameswar Rao

Detailed Summary

In the high-stakes world of mobile technology patents, securing an interim injunction can feel like winning the war before the first shot is fired. But what happens when the very party that secured that urgent relief is later accused of hiding the truth from the court? The clash between Ericsson and Xiaomi offers a masterclass in why candor before a judge is not optional — it is the price of admission to urgent relief.

Telefonaktiebolaget LM Ericsson, one of the world's most influential telecommunications companies, found itself in a familiar position for patent holders in the mobile era: alleging infringement. Ericsson sued Xiaomi Technology and others, claiming that Xiaomi's mobile devices infringed several of its standard-essential patents covering AMR (Adaptive Multi-Rate) codecs, 3G technology, and EDGE technology. Believing the matter was urgent, Ericsson sought and obtained an interim injunction against Xiaomi. Xiaomi, however, pushed back hard — not by arguing the merits of the patents themselves, but by attacking the very foundation of how Ericsson had obtained the order in the first place.

Xiaomi's strategy was surgical. Rather than wading into the complex technical arguments over AMR, 3G, and EDGE, Xiaomi filed an application seeking vacation of the interim injunction on a single, devastating ground: concealment of material facts. Xiaomi alleged that Ericsson had deliberately withheld a critical piece of information from the court when seeking the ex-parte order — specifically, an agreement Ericsson had with Qualcomm concerning CDMA applications. Ericsson, predictably, defended its conduct and the validity of the injunction it had secured. The legal friction was not about who invented what technology first; it was about whether the party asking for urgent relief had played fair with the tribunal.

The court sided with Xiaomi. It found that Ericsson had indeed failed to disclose its agreement with Qualcomm regarding CDMA applications — a fact the court deemed material to the claim being advanced. Because Ericsson had not met its heightened duty of candor as a party seeking an ex-parte injunction, the court vacated the interim order, at least with respect to two of the patents at issue. The ruling sent a clear message: an interim injunction is a powerful remedy, and it can be taken away just as quickly as it was granted if the applicant is found to have withheld relevant information from the court.

For founders, IP litigators, and startup leaders, the lesson is blunt and unforgiving: if you are seeking urgent relief from a court, you cannot cherry-pick the facts you present. The duty of disclosure is heightened precisely because the other side is not in the room to challenge you. Before filing for an ex-parte or interim injunction, conduct a rigorous internal audit of every related agreement, license, and prior arrangement — even those that seem tangential. One undisclosed contract can be the difference between a powerful injunction and a vacated order, and between a credible litigant and one the court no longer trusts.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Telefonaktiebolaget Lm Ericsson (Pub) vs Xiaomi Technology & Ors is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent923321

Aga Medical CorporationvsMr. Faisal Kapadi And Anr.

Aga Medical Corporation sought an ad-interim injunction against Mr. Faisal Kapadi and others, alleging that their manufacturing and sale of 'Blockaid' occlusion devices and use of similar brochures infringed on Aga's copyright and constituted passing off. The court examined the prima facie case, finding that the plaintiff failed to establish a clear case of infringement or deceptive similarity.

patent175178046

Yasmin Khalique And Ors.vsMukhtar Alam

This Calcutta High Court judgment addresses an appeal concerning a partnership dissolution and the associated registered trademark, 'Musa ka gul'. While the core dispute involves the validity of the arbitration award dissolving the firm, the court specifically addressed the use of the valuable trademark. The court clarified that ownership rights are not its immediate concern but issued a crucial interim order preventing either party from transferring or assigning any rights related to the mark until the appeal is finally decided.

patent25075539

Ankit Aggarwal Proprietor Of M/S Vepson EngineersvsGupta Casting Pvt. Ltd.

The Delhi High Court allowed petitions filed by Ankit Aggarwal to cancel two trademark registrations held by Gupta Casting Pvt. Ltd. The court found that the respondent's marks were confusingly similar to the petitioner's prior and well-established mark, 'JAI KISAN,' used since 1985 in agricultural implements. Furthermore, the respondent failed to demonstrate genuine use of their registered marks for a continuous period of five years, leading the court to remove them from the Register under Section 47 of the Trade Mark Act.

patent151574860

Raaj Unocal Lubricants LimitedvsApple Energy Pvt Ltd & Anr.

The Delhi High Court granted an interim injunction favoring Raaj Unocal Lubricants Limited. The court restrained the defendants from pursuing a related civil action before the U.S. District Court at Southern District of Texas, as well as preventing them from manufacturing or selling goods using trademarks identical or deceptively similar to UNOCAL and UNOCAL 76 in India. This decision protected the plaintiff's established rights derived from its licensing agreement with UNOCAL.

patent33727168

Sun Pharma Laboratories LimitedvsNova Indus Pharmaceuticals And Anr

Sun Pharma Laboratories Limited filed a commercial IP suit alleging trademark infringement and passing off against Nova Indus Pharmaceuticals. The court examined the extreme phonetic and structural similarity between the marks PANTOCID and PANZOCID, finding that there was a sufficient prima facie case.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call